Chronic myelogenous leukemia

Susan O'Brien, Camille N. Abboud, Mojtaba Akhtari, Jessica Altman, Ellin Berman, Daniel J. DeAngelo, Steven Devine, Amir T. Fathi, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Javier Pinilla-Ibarz, Jerald P. Radich, Vishnu V.B. Reddy, Neil P. Shah, Paul J. Shami, B. Douglas Smith, David S. Snyder, Meir Wetzler, Furhan Yunus

Research output: Contribution to journalReview article

18 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)64-110
Number of pages47
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Hematopoietic Stem Cell Transplantation
Homologous Transplantation
Protein Kinase Inhibitors
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Antineoplastic Agents
Imatinib Mesylate
Dasatinib
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide

Keywords

  • BCR-ABL
  • Chronic myelogenous leukemia
  • Dasatinib
  • Imatinib
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • Nilotinib
  • Stem cell transplant
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Oncology

Cite this

O'Brien, S., Abboud, C. N., Akhtari, M., Altman, J., Berman, E., DeAngelo, D. J., ... Yunus, F. (2012). Chronic myelogenous leukemia. JNCCN Journal of the National Comprehensive Cancer Network, 10(1), 64-110. https://doi.org/10.6004/jnccn.2012.0009

Chronic myelogenous leukemia. / O'Brien, Susan; Abboud, Camille N.; Akhtari, Mojtaba; Altman, Jessica; Berman, Ellin; DeAngelo, Daniel J.; Devine, Steven; Fathi, Amir T.; Gotlib, Jason; Jagasia, Madan; Moore, Joseph O.; Pinilla-Ibarz, Javier; Radich, Jerald P.; Reddy, Vishnu V.B.; Shah, Neil P.; Shami, Paul J.; Smith, B. Douglas; Snyder, David S.; Wetzler, Meir; Yunus, Furhan.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 10, No. 1, 01.01.2012, p. 64-110.

Research output: Contribution to journalReview article

O'Brien, S, Abboud, CN, Akhtari, M, Altman, J, Berman, E, DeAngelo, DJ, Devine, S, Fathi, AT, Gotlib, J, Jagasia, M, Moore, JO, Pinilla-Ibarz, J, Radich, JP, Reddy, VVB, Shah, NP, Shami, PJ, Smith, BD, Snyder, DS, Wetzler, M & Yunus, F 2012, 'Chronic myelogenous leukemia', JNCCN Journal of the National Comprehensive Cancer Network, vol. 10, no. 1, pp. 64-110. https://doi.org/10.6004/jnccn.2012.0009
O'Brien S, Abboud CN, Akhtari M, Altman J, Berman E, DeAngelo DJ et al. Chronic myelogenous leukemia. JNCCN Journal of the National Comprehensive Cancer Network. 2012 Jan 1;10(1):64-110. https://doi.org/10.6004/jnccn.2012.0009
O'Brien, Susan ; Abboud, Camille N. ; Akhtari, Mojtaba ; Altman, Jessica ; Berman, Ellin ; DeAngelo, Daniel J. ; Devine, Steven ; Fathi, Amir T. ; Gotlib, Jason ; Jagasia, Madan ; Moore, Joseph O. ; Pinilla-Ibarz, Javier ; Radich, Jerald P. ; Reddy, Vishnu V.B. ; Shah, Neil P. ; Shami, Paul J. ; Smith, B. Douglas ; Snyder, David S. ; Wetzler, Meir ; Yunus, Furhan. / Chronic myelogenous leukemia. In: JNCCN Journal of the National Comprehensive Cancer Network. 2012 ; Vol. 10, No. 1. pp. 64-110.
@article{56a10dc14ae0431e9bbd8623f22d3a61,
title = "Chronic myelogenous leukemia",
keywords = "BCR-ABL, Chronic myelogenous leukemia, Dasatinib, Imatinib, NCCN clinical practice guidelines, NCCN guidelines, Nilotinib, Stem cell transplant, Tyrosine kinase inhibitor",
author = "Susan O'Brien and Abboud, {Camille N.} and Mojtaba Akhtari and Jessica Altman and Ellin Berman and DeAngelo, {Daniel J.} and Steven Devine and Fathi, {Amir T.} and Jason Gotlib and Madan Jagasia and Moore, {Joseph O.} and Javier Pinilla-Ibarz and Radich, {Jerald P.} and Reddy, {Vishnu V.B.} and Shah, {Neil P.} and Shami, {Paul J.} and Smith, {B. Douglas} and Snyder, {David S.} and Meir Wetzler and Furhan Yunus",
year = "2012",
month = "1",
day = "1",
doi = "10.6004/jnccn.2012.0009",
language = "English (US)",
volume = "10",
pages = "64--110",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Chronic myelogenous leukemia

AU - O'Brien, Susan

AU - Abboud, Camille N.

AU - Akhtari, Mojtaba

AU - Altman, Jessica

AU - Berman, Ellin

AU - DeAngelo, Daniel J.

AU - Devine, Steven

AU - Fathi, Amir T.

AU - Gotlib, Jason

AU - Jagasia, Madan

AU - Moore, Joseph O.

AU - Pinilla-Ibarz, Javier

AU - Radich, Jerald P.

AU - Reddy, Vishnu V.B.

AU - Shah, Neil P.

AU - Shami, Paul J.

AU - Smith, B. Douglas

AU - Snyder, David S.

AU - Wetzler, Meir

AU - Yunus, Furhan

PY - 2012/1/1

Y1 - 2012/1/1

KW - BCR-ABL

KW - Chronic myelogenous leukemia

KW - Dasatinib

KW - Imatinib

KW - NCCN clinical practice guidelines

KW - NCCN guidelines

KW - Nilotinib

KW - Stem cell transplant

KW - Tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84863415772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863415772&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2012.0009

DO - 10.6004/jnccn.2012.0009

M3 - Review article

VL - 10

SP - 64

EP - 110

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 1

ER -